Speaker illustration

Doctor Valentina Cannone

Mayo Clinic, Department of Cardiovascular Disease, Rochester (United States of America)

The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography


Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community

Event: ESC CONGRESS 2016

Topic: Neurohormones

Session: Neuro-hormonal activation: target in HF


Metabolic disease in the general population: a potential cyclic GMP deficiency states

Event: ESC CONGRESS 2016

Topic: Epidemiology, lipids

Session: Cardiovascular risk in populations


This platform is supported by

logo Novo Nordisk